Transforming growth factor-beta in the pathogenesis of chronic obstructive pulmonary disease

References

• Massagué J, Chen YG. Controlling TGF-beta signaling. Genes Dev 2000; 14: 627–44
   PubMed Web of Science ®Google Scholar
• Hogan BLM. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996; 10: 1580–94
   PubMed Web of Science ®Google Scholar
• Ma B, Blackburn MR, Lee CG, Homer RJ, Liu W, Flavell RA, et al. Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis. J Clin Invest 2006; 116: 1274–83
   PubMed Web of Science ®Google Scholar
• Xu YD, Hua J, Mui A, O'Connor R, Grotendorst G, Khalil N. Release of biological active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2003; 285: L527–39
   PubMed Web of Science ®Google Scholar
• Leivonen SK, Hakkinen L, Liu D, Kahari VM. Smad 3 and extracellular signal-regulated kinase 1/2 coordinately mediate transforming growth factor-beta-induced expression of connective tissue growth factor in human fibroblast. J Invest Dermatol 2005; 124: 1162–9
   PubMed Web of Science ®Google Scholar
• Samarakoon R, Higgins CE, Higgins SP, Kutz SM, Higgins PJ. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta 1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent. J Cell Physiol 2005; 204: 236–46
   PubMed Web of Science ®Google Scholar
• Perng D, Wu Y, Chang K, Wu MT, Chiou YC, Su KC, et al. Leukotriene C4 induces TGF-beta1 production in airway epithelium via p38 kinase pathway. Am J Respir Cell Mol Biol 2006; 34: 101–7
   PubMed Web of Science ®Google Scholar
• Kaminska B, Wesolowska A, Danilkiewicz M. TGF-beta signaling and its role in tumor pathogenesis. Acta Biochim Pol 2005; 52: 329–37
   PubMed Web of Science ®Google Scholar
• Rochester CL, Ackerman SJ, Zheng T, Elias JA. Eosinophil–fibroblast interactions. Granule major basic protein interact with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6 type cytokine production. J Immunol 1996; 156: 4449–56
   PubMed Web of Science ®Google Scholar
• Wen F, Liu X, Kabayashi T, Abe S, Fang Q, Kohyama T, et al. Interferon-gamma inhibits transforming growth factor production in human airway epithelial cells by targeting Smads. Am J Respir Cell Mol Biol 2004; 30: 816–22
   PubMed Web of Science ®Google Scholar
• Hyytiäinen M, Penttinen C, Keski-Oja J. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 2004; 41: 233–64
   PubMed Web of Science ®Google Scholar
• Khalil N. TGF-beta: from latent to active. Microbes Infect 1999; 15: 1255–63
   Web of Science ®Google Scholar
• Chen G, Grotendorst G, Eichholtz T, Khalil N. GM-CSF increases airway smooth muscle cell connective tissue expression by inducing TGF-beta receptors. Am J Physiol Lung Cell Mol Physiol 2003; 284: L548–56
   Web of Science ®Google Scholar
• Khalil N, Xu YD, O'Connor R, Duronio V. Proliferation of pulmonary interstitial fibroblast is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK. J Biol Chem 2005; 280: 43000–9
   PubMed Web of Science ®Google Scholar
• Makinde T, Murphy RF, Agrawal DK. The regulatory role of TGF-beta in airway remodeling in asthma. Immunol Cell Biol 2007; 85: 348–56
   PubMed Web of Science ®Google Scholar
• Heldin CH, Miyazono K, Dijke PT. TGF-beta signaling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390: 465–71
   PubMed Web of Science ®Google Scholar
• Qing J, Zhang Y, Derynck R. Structural and functional characterization of the transforming growth factor beta-induced Smad3/c-Jun transcriptional cooperativity. J Biol Chem 2000; 275: 38802–12
   PubMed Web of Science ®Google Scholar
• Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, et al. Functional characterization of transforming growth factor beta signaling in Smad2 and Smad 3-deficient fibroblasts. J Biol Chem 2001; 276: 19945–53
   PubMed Web of Science ®Google Scholar
• Zhang Y, Feng X, Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 1998; 394: 909–13
   PubMed Web of Science ®Google Scholar
• Horowitz JC, Lee DY, Waghray M, Keshamouni VG, Thomas PE, Zhang H, et al. Activation of the pro-survival phosphotidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38-MAPK-dependent induction of an autocrine growth factor. J Biol Chem 2004; 279: 1359–67
   PubMed Web of Science ®Google Scholar
• Attisano L, Wrana JL. Smads as transcriptional co-modulators. Curr Opin Cell Biol 2000; 12: 235–43
   PubMed Web of Science ®Google Scholar
• Massagué J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000; 19: 1745–54
   PubMed Web of Science ®Google Scholar
• Itoh S, Itoh F, Goumans MJ, ten Dijke P. Signaling of transforming growth factor-beta family members through Smad proteins. Eur J Biochem 2000; 267: 6954–67
   PubMedGoogle Scholar
• Derynck R, Zhang Y, Feng XF. Smads: transcriptional activators of TGF-beta responses. Cell 1998; 95: 737–40
   PubMed Web of Science ®Google Scholar
• Massagué J. TGF-beta signal transduction. Annu Rev Biochem 1998; 67: 753–91
   PubMed Web of Science ®Google Scholar
• Howell M, Itoh F, Pierreux CE, Valgeirsdottir S, Itoh S, ten Dijke P, et al. Xenopus Smad4β is the co-Smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes. Dev Biol 1999; 214: 354–69
   PubMed Web of Science ®Google Scholar
• Masuyama N, Hanafusa H, Kusakabe M, Shibuya H, Nishida E. Identification of two Smad4 proteins in Xenopus. Their common and distinct properties. J Biol Chem 1999; 274: 12163–70
   PubMed Web of Science ®Google Scholar
• Yamauchi K, Tohoku J. Airway remodeling in asthma and its influence on clinical pathophysiology. Exp Med 2006; 209: 75–87
   Web of Science ®Google Scholar
• Postma DS, Timens W. Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3: 434–9
   PubMedGoogle Scholar
• Utsugi M, Dobashi K, Ishizuka T, Masubuchi K, Shimizu Y, Nakazawa T, et al. C-Jun-NH2-terminal kinase-mediated expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts. Am J Respir Cell Mol Biol 2003; 28: 754–61
   PubMed Web of Science ®Google Scholar
• Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342: 1350–8
   PubMed Web of Science ®Google Scholar
• Lawrence DA. Transforming growth factor-beta: a general review. Eur Cytokine Netw 1996; 7: 363–74
   PubMed Web of Science ®Google Scholar
• Bosse Y, Thompson C, Stankova J, Rola-Pleszczynski M. Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation. Am J Respir Cell Mol Biol 2006; 34: 746–53
   PubMed Web of Science ®Google Scholar
• Zhang HY, Phan SH. Inhibition of myofibroblast apoptosis by transforming growth factor beta(1). Am J Respir Cell Mol Biol 1999; 21: 658–65
   PubMed Web of Science ®Google Scholar
• Gruber BL, Marchese MJ, Kew RR. Transforming growth factor-beta1 mediates mast cell chemotaxis. J Immunol 1994; 152: 5860–7
   PubMed Web of Science ®Google Scholar
• de Boer WI, van Schadewijk A, Sont JK, Sharma HS, Stolk J, Hiemstra PS, et al. Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1951–7
   PubMed Web of Science ®Google Scholar
• Aubert JD, Hayashi S, Hards J, Bai TR, Pare PD, Hogg JC. Platelet- derived growth factor and its receptor in lungs from patients with asthma and chronic airflow obstruction. Am J Physiol 1994; 266: L655–63
   Google Scholar
• Takizawa H, Beckmann JD, Yoshida M, Romberger D, Rennard S. Regulation of bovine bronchial epithelial cell proliferation and proto-oncogene expression by growth factors. Am J Respir Cell Mol Biol 1991; 5: 548–55
   PubMed Web of Science ®Google Scholar
• Jurjus A, Atiyeh BS, Abdallah IM, Jurjus RA, Hayek SN, Jaoude MA, et al. Pharmacological modulation of wound healing in experimental burns. Burns 2007; 33: 892–907
   PubMed Web of Science ®Google Scholar
• Flanders KC, Ren RF, Lippa CF. Transforming growth factor-betas in neurodegenerative disease. Prog Neurobiol 1998; 54: 71–85
   PubMed Web of Science ®Google Scholar
• Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331: 1286–92
   PubMed Web of Science ®Google Scholar
• Ohmori H, Kanda T, Takai T, Hikida M. Induction of antigen-specific IgE response in murine lymphocytes by IL-10. Immunol Lett 1995; 47: 127–32
   PubMed Web of Science ®Google Scholar
• Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L. Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 1998; 158: 1958–62
   PubMed Web of Science ®Google Scholar
• Kenyon NJ, Ward RW, McGrew G, Last JA. TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice. Thorax 2003; 58: 772–7
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532–55
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Evidence-based health policy—lessons from the Global Burden of Disease Study. Science 1996; 274: 740–3
   PubMed Web of Science ®Google Scholar
• Heaney LG, Lindsay JT, McGarvey LP. Inflammation in chronic obstructive pulmonary disease: implications for new treatment strategies. Curr Med Chem 2007; 14: 787–96
   PubMed Web of Science ®Google Scholar
• Jeffery PK. Morphology of the airway wall in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143: 1152–8
   PubMed Web of Science ®Google Scholar
• Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, van der Mark TW, Koëter GH, et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000; 55: 12–18
   PubMed Web of Science ®Google Scholar
• Tetley TD. Inflammatory cells and chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy 2005; 4: 607–18
   PubMedGoogle Scholar
• Yim JJ, Park GY, Lee CT, Kim YW, Han SK, Shim YS, et al. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 2000; 55: 121–5
   PubMed Web of Science ®Google Scholar
• Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 2003; 28: 12–24
   PubMed Web of Science ®Google Scholar
• Barnes PJ. New treatments for COPD. Nat Rev Drug Discov 2002; 1: 437–46
   PubMed Web of Science ®Google Scholar
• Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827–39
   PubMed Web of Science ®Google Scholar
• Calabrese F, Giacometti C, Beghe B, Rea F, Loy M, Zuin R. Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema. Respir Res 2005; 6: 14
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busjletic K, Turato G, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 418–24
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77–121.
   PubMed Web of Science ®Google Scholar
• El Mabrouk, M, Qureshi, HY, Li, WQ, Sylvester, J, Zafarullah, M. Interleukin-4 antagonizes oncostatin M and transforming growth factor beta-induced responses in articular chondrocytes. J Cell Biochem 2007;Jun 1, Epub ahead of print
   Web of Science ®Google Scholar
• Zhong XN, Bai J, Shi HZ, Wu C, Liang GR, Feng ZB. An experimental study on airway inflammation and remodeling in a rat model of chronic bronchitis and emphysema. Zhonghua Jie He He Hu Xi Za Zhi 2003; 26: 750–5
   PubMedGoogle Scholar
• Sugiura H, Liu X, Kobayashi T, Togo S, Ertl RF, Kawasaki S, et al. Reactive nitrogen species augment fibroblast-mediated collagen gel contraction, mediator production, and chemotaxis. Am J Respir Cell Mol Biol 2006; 34: 592–9
   PubMed Web of Science ®Google Scholar
• Wahl SM, Hunt DA, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A 1987; 84: 5788–92
   PubMed Web of Science ®Google Scholar
• Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 2002; 109: 41–50
   PubMed Web of Science ®Google Scholar
• Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001; 17: 946–53
   PubMed Web of Science ®Google Scholar
• Hodge SJ, Hodge GL, Reynolds PN, Scicchitano R, Holmes M. Increased production of TGF-beta and apoptosis of T lymphocytes isolated from peripheral blood in COPD. Am J Physiol Lung Cell Mol Physiol 2003; 285: L492–9
   PubMed Web of Science ®Google Scholar
• Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16: 137–61
   PubMed Web of Science ®Google Scholar
• Vyas-Read S, Shaul PW, Yuhanna IS, Willis BC. Nitric oxide attenuates epithelial–mesenchymal transition in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2007; 293: L212–21
   PubMed Web of Science ®Google Scholar
• Maestrelli P, Saetta M, Mapp CE, Fabbri LM. Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: S76–80
   PubMed Web of Science ®Google Scholar
• Erjefalt JS, Erjefalt I, Sundler F, Persson CG. In vivo restitution of airway epithelium. Cell Tissue Res 1995; 281: 305–16
   PubMed Web of Science ®Google Scholar
• Holgate ST. Epithelial damage and response. Clin Exp Allergy 2000; 30(Suppl 1)37–41
   PubMed Web of Science ®Google Scholar
• Polunovsky VA, Chen B, Henke C, Snover D, Wendt C, Ingbar DH, et al. Role of mesenchymal cell death in lung remodeling after injury. J Clin Invest 1993; 92: 388–97
   PubMed Web of Science ®Google Scholar
• MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 258–66
   PubMedGoogle Scholar
• Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese RJ, Jr, et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 2000; 106: 1081–93
   PubMed Web of Science ®Google Scholar
• Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, et al. Loss of integrin alphavbeta6-mediated TGF-beta activation causes MMP12-dependent emphysema. Nature 2003; 422: 169–73
   PubMed Web of Science ®Google Scholar
• Eickelberg O, Kohler E, Reichenberger F, Bertschin S, Woodtli T, Erne P, et al. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am J Physiol 1999; 276: L814–24
   PubMed Web of Science ®Google Scholar
• Fang KC, Wolters PJ, Steinhoff M, Bidgol A, Blount JL, Caughey GH. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. J Immunol 1999; 162: 5528–35
   PubMed Web of Science ®Google Scholar
• Lanone S, Zheng T, Zhu Z, Liu W, Lee CG, Ma B, et al. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest 2002; 110: 463–74
   PubMed Web of Science ®Google Scholar
• Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002; 26: 602–9
   PubMed Web of Science ®Google Scholar
• Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, et al. The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med 1995; 1: 74–9
   PubMed Web of Science ®Google Scholar
• Beghe B, Bazzan E, Baraldo S, Calabrese F, Rea F, Loy M, et al. Transforming growth factor-beta type II receptor in pulmonary arteries of patients with very severe COPD. Eur Respir J 2006; 28: 556–62
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Liu X, Wen FQ, Fang Q, Abe S, Wang XQ. Smad3 mediates TGF-beta1 induction of VEGF production in lung fibroblasts. Biochem Biophys Res Commun 2005; 327: 393–8
   PubMed Web of Science ®Google Scholar
• Chetta A, Zanini A, Foresis A, Díppolito R, Tipa A, Castagnaro A. Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma. Clin Exp Allergy 2005; 35: 1437–42
   PubMed Web of Science ®Google Scholar
• Cataldo DD, Gueders MM, Rocks N, Sounni NE, Evrard B, Bartsch P, et al. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors. Cell Mol Biol (Noisy-le-grand) 2003; 49: 875–84
   PubMed Web of Science ®Google Scholar
• Finlay GA, Russell KJ, McMahon KJ, D'Arcy EM, Masterson JB, FitzGerald MX, et al. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 1997; 52: 502–6
   PubMed Web of Science ®Google Scholar
• Vignola AM, Riccobono L, Mirabella A, Profita M, Chanez P, Bellia V, et al. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998; 158: 1945–50
   PubMed Web of Science ®Google Scholar
• Culpitt SV, Rogers DF, Traves SL, Barnes PJ, Donnelly LE. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. Respir Med 2005; 99: 703–10
   PubMed Web of Science ®Google Scholar
• Mercer PF, Shute JK, Bhowmik A, Donaldson GC, Wedzicha JA, Warner JA. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res 2005; 226: 151
   Web of Science ®Google Scholar
• Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, et al. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature 2003; 422: 169–73
   PubMed Web of Science ®Google Scholar
• Brøgger J, Steen VM, Eiken HG, Gulsvi A, Bakke P. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur Respir J 2006; 27: 682–8
   PubMed Web of Science ®Google Scholar
• Wallace SE, Lachman RS, Mekikian PB, Bui KK, Wilcox WR. Marked phenotypic variability in progressive diaphyseal dysplasia (Camurati-Engelmann disease): report of a four-generation pedigree, identification of a mutation in TGFB1, and review. Am J Med Genet A 2004; 129: 235–47
   Web of Science ®Google Scholar
• Langdahl BL, Knudsen JY, Jensen HK, Gregersen N, Eriksen EF. A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 1997; 20: 289–94
   PubMed Web of Science ®Google Scholar
• Awad M, El-Gamel A, Hasleton P, Turner DM, Sinnot PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene. Transplantation 1998; 66: 1014–20
   PubMed Web of Science ®Google Scholar
• Lympany PA, Avila JJ, Mullighan C, Marshall S, Welsh KI, du Bois RM. Rapid genotyping of transforming growth factor-beta1 gene polymorphisms in a UK Caucasoid control population using the polymerase chain reaction and sequence-specific primers. Tissue Antigens 1998; 52: 573–8
   PubMedGoogle Scholar
• Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, et al. Association of a polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 1998; 13: 1569–76
   PubMed Web of Science ®Google Scholar
• Yamada Y, Okuizumi H, Miyauchi A, Takagi Y, Ikeda K, Harada A. Association of transforming growth factor beta1 genotype with spinal osteophytosis in Japanese women. Arthritis Rheum 2000; 43: 452–60
   PubMed Web of Science ®Google Scholar
• Syrris P, Carter ND, Metcalfe JC, Kemp PR, Grainger DJ, Kaski JC, et al. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci 1998; 95: 659–67
   PubMed Web of Science ®Google Scholar
• Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, et al. Polymorphisms of the transforming growth factor-beta1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 1996; 28: 881–7
   PubMed Web of Science ®Google Scholar
• Holweg CT, Baan CC, Balk AH, Niesters HG, Maat AP, Mulder PM, et al. The transforming growth factor-beta1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation 2001; 71: 1463–7
   PubMed Web of Science ®Google Scholar
• Ziv E, Cauley J, Morin PA, Saiz R, Browner WS. Association between the T29– > C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures. JAMA 2001; 285: 2859–63
   PubMed Web of Science ®Google Scholar
• Baan CC, Balk AH, Holweg CT, vanRiemsdijk IC, Maat LP, Vantrimpont PJ, et al. Renal failure after clinical heart transplantation is associated with the TGF-beta 1 codon 10 gene polymorphism. J Heart Lung Transplant 2000; 19: 866–72
   PubMed Web of Science ®Google Scholar
• Arkwright PD, Chase JM, Babbage S, Pravica V, David TJ, Hutchinson IV. Atopic dermatitis is associated with a low-producer transforming growth factor beta (1) cytokine genotype. J Allergy Clin Immunol 2001; 108: 281–4
   PubMed Web of Science ®Google Scholar
• Densem CG, Hutchinson IV, Cooper A, Yonan N, Brooks NH. Polymorphism of the transforming growth factor beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation. J Heart Lung Transplant 2000; 19: 551–6
   PubMed Web of Science ®Google Scholar
• Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998; 66: 1014–20
   PubMed Web of Science ®Google Scholar
• Li B, Khanna A, Sharma V, Singh T, Suthanthiran M, August P. TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 1999; 33: 271–5
   PubMed Web of Science ®Google Scholar
• Wu L, Chau J, Young RP, Pokorny V, Mills GD, Hopkins R, et al. Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 2004; 59: 126–9
   PubMed Web of Science ®Google Scholar
• Liebhart J, Polak M, Dobek R, Liebhart E, Dor A, Kulczak A, et al. TGF-beta1 gene polymorphism in chronic obstructive pulmonary disease. Pneumonol Alergol Pol 2005; 73: 216–20
   PubMedGoogle Scholar
• Yoon HI, Silverman EK, Lee HW, Yoo CG, Lee CT, Chung HS, et al. Lack of association between COPD and transforming growth factor-beta1 (TGFbeta1) genetic polymorphisms in Koreans. Int J Tuberc Lung Dis 2006; 10: 504–9
   PubMed Web of Science ®Google Scholar
• Su ZG, Wen FQ, Feng YL, Xiao M, Wu XL. Transforming growth factor-beta1 gene polymorphisms associated with chronic obstructive pulmonary disease in Chinese population. Acta Pharmacol Sin 2005; 26: 714–20
   PubMed Web of Science ®Google Scholar
• Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, et al. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2001; 163: 1476–83
   PubMed Web of Science ®Google Scholar
• DaCosta Byfield S, Major C, Laping NJ, Roberts AB. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2004; 65: 744–52
   PubMed Web of Science ®Google Scholar
• Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002; 62: 65–74
   PubMed Web of Science ®Google Scholar
• Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, et al. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 2002; 62: 58–64
   PubMed Web of Science ®Google Scholar